Lastly, the antiangiogenic protein Insulin-like Growth Factor-Binding Protein 3 (IGFBP-3) was also tested on HNSCC and was found to significantly reduce ERK1/2 and ELK1 activation [47]. This evidence concerns the gene ELK1 and head and neck squamous cell carcinoma.